Clinical trial reportActa haematologicaPublished
Anexelekto (Axl)/Mer Inhibitor Tamnorzatinib in Patients with Relapsed/Refractory Acute Myeloid Leukaemia: Results from a Phase I (Monotherapy) and Phase II (Combination with Venetoclax) Clinical Study
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Acta haematologica
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Recurrence; Sulfonamides; Proto-Oncogene Proteins; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Adult; Aged; Middle Aged; Female; Male; Leukemia, Myeloid, Acute
- PubMed ID
- 41385448
- PubMed Central ID
- PMC12795523
- Open access
- Yes, open
- Added to directory
- Source checked